Akros

Manufacturing · New Jersey, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

302 Carnegie Ctr Ste 300, Princeton, New...

Phone Number

(609) 919-9570

Revenue

$13.5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1

About Akros

Akros Pharma Inc. is a U.S.-based pharmaceutical company dedicated to the development of innovative pharmaceutical products for both domestic and global markets. Serving as the American operations of the Japanese pharmaceutical leader Shionogi & Co., Ltd., Akros Pharma leverages the parent companys expertise in drug discovery and development to advance therapies that address critical medical needs. The company focuses on bringing high-quality, effective medicines to patients while maintaining a commitment to transparency, collaboration, and regulatory compliance.Explore more
Popular SearchesAkros Pharma IncAkros PharmaAkros Pharmacy IncAkrospharmaSIC Code 28,283NAICS Code 32,325Show more

Akros Org Chart

TH
United States flag for contact location.

President & Chief Executive Officer

PhoneEmail
SH
United States flag for contact location.

Executive VP, Clinical Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
TN
United States flag for contact location.

Vice President, Clinical Development

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Akros your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Akros

Compare insights from companies similar to Akros, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Akros

$13.5M
11-50
Private
-
1999
TH
Teppei HiguchiPresident & CEO
$6.9M
11-50
Private
$96.2M
2006
BB
Barb BaasGlobal Controller
<$5M
11-50
Private
$37.9M
2004
TN
Takuma NakatsukaChief Financial Officer
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
2006
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2013
Ketan Desai, Chief Medical Officer at Levolta Pharmaceuticals
Ketan DesaiChief Medical Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Akros is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Akros is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Akros.

Akros Tech Stack

A closer look at the technologies used by Akros

Most Recent Scoops

Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Pain Point
Project
A mid-level source in medical & health has indicated that the organization is planning to remediate challenges related to digital transformation. Rui Zhuo currently serves as Senior Director, Clinical Data Sciences.
Data Science, Digital Technology
Pain Point
Project
A mid-level source in medical & health has indicated that the organization is planning to remediate challenges related to computer-assisted coding. Rui Zhuo currently serves as Senior Director, Clinical Data Sciences.
Data Science, Document Management
Project
A mid-level source in medical & health has indicated that the organization has completed initiatives related to appointment management within the last nine months.
Pain Point
Project
Clinical Systems, Data Science
See more scoops

Akros News & Media

  • Shionogi pushes 2030 vision forward with $1 billion acquisition | Pharmaceutical | The Pharmaletter

    Japanese drugmaker Shionogi (TYO: 4507) is to scale up its pipeline and global ambitions with a deal worth more than $1 billion, buying the pharmaceutical operations of Japan Tobacco, including its US subsidiary Akros Pharma. The agreement, announced Wednesday, will also see Shionogi acquire full control of Torii Pharmaceutical, which is currently majority-owned by Japan Tobacco. The Osaka-based group will spend around 150 billion yen ($1.05 billion) in total, including roughly 70 billion yen fo
Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Akros

What is Akros's official website?
Akros's official website is www.akrospharma.com
What is Akros's Revenue?
Akros's revenue is $13.5 Million
What is Akros's SIC code?
Akros's SIC: 28,283
What is Akros's NAICS code?
Akros's NAICS: 32,325
How many employees does Akros have?
Akros has 11-50 employees
What industry does Akros belong to?
Akros is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Akros competition?
Akros top competitors include: Novoclinica, Pipeline Drugs, NapaJen Pharma, Levolta Pharmaceuticals
What companies has Akros acquired?
Akros has acquired the companies: Sciele Pharma, Addrenex Pharmaceuticals, Twinject, Alliant Pharmaceuticals
What technology does Akros use?
Some of the popular technologies that Akros uses are: WordPress.org, PHP, Proofpoint, Google Font API
How do I contact Akros?
Akros contact info: Phone number: (609) 919-9570 Website: www.akrospharma.com
What does Akros do?

Akros Pharma Inc. is a U.S.-based pharmaceutical company dedicated to the development of innovative pharmaceutical products for both domestic and global markets. Serving as the American operations of the Japanese pharmaceutical leader Shionogi & Co., Ltd., Akros Pharma leverages the parent companys expertise in drug discovery and development to adv... ance therapies that address critical medical needs. The company focuses on bringing high-quality, effective medicines to patients while maintaining a commitment to transparency, collaboration, and regulatory compliance.Read More

Is Akros a public company?
Akros is private company therefore does not currently have an official ticker symbol
See more information about Akros

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.